Trial intelligence / Profile preview

Preemptive norepinephrine hemodynamic management to prevent intraoperative hypothermia in major hepatobiliary and pancreatic surgery

KCT0011840Phase 4Completed

Sponsor
Asan Medical Center
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of norepinephrine in hepatocellular carcinoma (HCC), pancreatic cancer (PC), sponsored by Asan Medical Center. Started Apr 2026; status: completed.

02

Drugs

norepinephrine
03

Conditions

hepatocellular carcinoma (HCC)pancreatic cancer (PC)

Beyond the preview

Go deeper on KCT0011840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0011840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call